... equity investment, development funding, and product development and sales milestones ($68 million). Sale of worldwide generic injectable paclitaxel business to Mayne ...
... equity investment, development funding, and product development and sales milestones ($68 million). Sale of worldwide generic injectable paclitaxel business to Mayne ...